Low Dose Versus Normal Dose Ketorolac for Postoperative Pain After Prostatectomy and Hysterectomy
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A monocenter, prospective, double-blind, randomized controlled non-inferiority trial will be
designed to investigate if ketorolac 10 mg is as effective for pain relief as the standard
dose of 30 mg in patients undergoing robot assisted radical prostatectomy (RARP) or
hysterectomy by laparoscopic assisted vaginal hysterectomy (LAVH) or total laparoscopic
hysterectomy (TLH). It is hypothesised that the postoperative pain score at rest at 8 hours
after surgery when receiving ketolorac 10 mg is non-inferior to the pain score at rest when
receiving ketolorac 30mg.